The A2 Milk Company Limited (ACOPY) Q2 2024 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for standing by and welcome to the A2 Milk Company Limited first half 24 results call. All participants are in a listen only mode. There will be a presentation followed by a question and answer session. If you wish to ask a question, you'll need to press the star key followed by the number one on your telephone keypad. I would now like to hand the conference over to Mr. David Akers, Head of Investor Relations and Sustainability. Please go ahead. Good morning, everyone. Thanks for joining the call today. Starting on slide three. On the call today, we have David Ward-Lucy, our Managing Director and CEO, and Dave Musk at our CFO. We also have leaders from our regions, Lee Zhao, Johansson Aratne, Eleanor Corr, and Kevin Bush. The team will present our results and outlook, and there'll be time for questions at the end. I'll hand over now to David Ward-Lucy. Thank you, David. Good morning, everyone, and thanks for joining us all. I'd like to get through today, so I'll start with a few key messages. Firstly, we're pleased to report a positive interim result today, with revenue growth at 3.7%, EBITDA up 5%. We're in total IMF sales, despite another double-digit decline in the China IMF sales. The result of the NAICS will actually be an important milestone, becoming a top five brand in the China Atlantis market overall, including China Laser. In doing so, our brand health metrics reach new highs, supported by record levels. During the period, we successfully launched our new GDP registered China label product, and we are pleased to confirm that the transition is ahead of plan. Encouragingly, after several periods of decline, English label sales stabilised in the first half of 24 compared to the second half of 23. We also have additional English label products coming...